Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia. Study co-author Jennifer Schneiderman, MD, discusses results, published in the New England Journal of Medicine.
